TrialInternational journal of cancer2025

Twenty-year survival outcomes after multipeptide vaccination for resected high-risk melanoma: A post-hoc analysis of a randomized clinical trial.

Emily K Ninmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.